INBRIJA®

GUDID 00310144300011

Acorda Therapeutics, Inc.

Dry powder inhaler

• Primary Device ID: 00310144300011
• NIH Device Record Key: e1d0cf31-04c6-4d02-a798-dcbdd3f0967d
• Commercial Distribution Status: In Commercial Distribution
• Brand Name: INBRIJA®
• Version Model Number: Inbrija Device
• Company DUNS: 963845136
• Company Name: Acorda Therapeutics, Inc.
• Device Count: 1
• DM Exempt: false
• Pre-market Exempt: true
• MRI Safety Status: Labeling does not contain MRI Safety Information
• Human Cell/Tissue Product: false
• Device Kit: false
• Device Combination Product: false
• Single Use: false
• Lot Batch: true
• Serial Number: false
• Manufacturing Date: false
• Expiration Date: false
• Donation Id Number: false
• Contains Natural Rubber Latex: false
• Labeled No Natural Rubber Latex: true
• RX Perscription: true
• OTC Over-The-Counter: false

Customer Support Contacts

• Phone: +1(800)367-5109
• Email: acordamc@eversana.com
• Phone: +1(800)367-5109
• Email: acordamc@eversana.com
• Phone: +1(800)367-5109
• Email: acordamc@eversana.com
• Phone: +1(800)367-5109
• Email: acordamc@eversana.com
• Phone: +1(800)367-5109
• Email: acordamc@eversana.com
• Phone: +1(800)367-5109
• Email: acordamc@eversana.com
• Phone: +1(800)367-5109
• Email: acordamc@eversana.com
• Phone: +1(800)367-5109
• Email: acordamc@eversana.com

Device Identifiers

Device Issuing Agency	Device ID
GS1	00310144300011 [Primary]

FDA Product Code

• KCO: Nasal spray, ENT delivery

Sterilization

• Steralize Prior To Use: false
• Device Is Sterile: false

Device Entry Metadata

• Public Version Status: New
• Device Record Status: Published
• Public Version Number: 1
• Public Version Date: 2022-12-06
• Device Publish Date: 2022-11-28